Skip to main content
logo
Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.000
+0.080 (2.74%)
At close: Sep 8, 2026

Coegin Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.430.08----
Revenue Growth
------
Gross Profit
-0.77-0.77-0.02-0.02--
Operating Income
-21.61-20.45-23.33-27.82-34.69-27.18
Net Income
-21.71-20.5-23.78-27.98-35.24-27.15
Earnings Per Share
-0.87-0.82-1.26-3.04-5.14-4.59
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
2.487.9219.685.553.8225.66
Net Cash Growth
-79.89%-59.74%254.70%45.39%-85.13%54.12%
Net Cash Per Share
0.100.321.040.600.564.32
Cash & Investments
2.487.9219.685.553.8225.66

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.71-16.55-23.64-22.03-38.23-21.49
Capital Expenditures
-0.09-0.12----
Free Cash Flow
-21.8-16.67-23.64-22.03-38.23-21.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-4990.53%-25889.87%----
Pretax Margin
-5009.01%-25925.32%----
Profit Margin
-5012.70%-25945.57%----
FCF Margin
-5035.34%-21101.27%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
198.091398.18----